Search Results - "Labarga, P."

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients by Fernández-Montero, José Vicente, Vispo, Eugenia, Barreiro, Pablo, Sierra-Enguita, Rocío, de Mendoza, Carmen, Labarga, Pablo, Soriano, Vincent

“…Background. Coinfection with hepatitis viruses is common in individuals infected with human immunodeficiency virus (HIV) and has become a leading cause of…”
Get full text

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients by Fernández-Montero, J. V., Barreiro, P., de Mendoza, C., Labarga, P., Soriano, V.

“…Summary Patients infected with HIV are at increased risk for cardiovascular disease despite successful antiretroviral therapy. Likewise, chronic hepatitis C…”
Get full text

Directly acting antivirals against hepatitis C virus by Soriano, Vincent, Vispo, Eugenia, Poveda, Eva, Labarga, Pablo, Martin-Carbonero, Luz, Fernandez-Montero, Jose Vicente, Barreiro, Pablo

“…The approval of directly acting antivirals (DAA) for the treatment of chronic hepatitis C virus (HCV) infection will represent a major breakthrough for the 180…”
Get full text

P0838 : Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and prioritization of new hepatitis C therapies by Labarga, P, Barreiro, P, de Mendoza, C, Soriano, V

Get full text

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance by Blanco, F., Barreiro, P., Ryan, P., Vispo, E., Martín-Carbonero, L., Tuma, P., Labarga, P., Medrano, J., González-Lahoz, J., Soriano, V.

“…Liver damage may result from multiple factors in HIV‐infected patients. The availability of reliable noninvasive tools to measure liver fibrosis has permitted…”
Get full text

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome by Castellares, C., Barreiro, P., Martín-Carbonero, L., Labarga, P., Vispo, M. E., Casado, R., Galindo, L., García-Gascó, P., García-Samaniego, J., Soriano, V.

“…Liver disease is frequently seen in HIV+ patients as a result of coinfection with hepatitis B (HBV) or C (HCV) viruses, alcohol abuse and/or exposure to…”
Get full text

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy by De Lédinghen, V., Barreiro, P., Foucher, J., Labarga, P., Castéra, L., Vispo, M. E., Bernard, P.-H., Martin-Carbonero, L., Neau, D., García-Gascó, P., Merrouche, W., Soriano, V.

“…The recent availability of non‐invasive tools to measure liver fibrosis has allowed examination of its extent and determination of predictors in all patients…”
Get full text

Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy by Labarga, P., Fernandez-Montero, J. V., Barreiro, P., Pinilla, J., Vispo, E., de Mendoza, C., Plaza, Z., Soriano, V.

“…Summary There is scarce information about the impact of antiviral treatment on subsequent progression of liver fibrosis in HIV‐infected patients with chronic…”
Get full text

P751 DISTINCT VALUES OF LIVER STIFFNESS PREDICT PROGRESSION TO ADVANCED LIVER FIBROSIS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C by Labarga, P, Fernandez-Montero, J.V, Barreiro, P, Vispo, M.E, Sierra, R, Perez, I, de Mendoza, C, Soriano, V

Get full text

P750 SPONTANEOUS HCV CLEARANCE IN HIV PATIENTS WITH CHRONIC HEPATITIS C BEARING FAVORABLE IL28B ALLELES ON ANTIRETROVIRAL THERAPY by Vispo, E, Barreiro, P, Fernandez-Montero, J.V, Labarga, P, de Mendoza, C, Treviño, A, Soriano, V

Get full text

P1068 EFFICACY OF PROLONGED TENOFOVIR THERAPY ON HEPATITIS DELTA IN HIV-INFECTED PATIENTS by Sierra-Enguita, R, Vispo, E, Barreiro, P, de Mendoza, C, Fernandez-Montero, J.V, Labarga, P, Soriano, V

Get full text

Association of low-density lipoprotein receptor genotypes with hepatitis C viral load by Caruz, A, Neukam, K, Rivero-Juárez, A, Herrero, R, Real, L M, Camacho, Á, Barreiro, P, Labarga, P, Rivero, A, Pineda, J A

“…Several data suggest that low-density lipoprotein receptor (LDLR) is a co-receptor for hepatitis C virus (HCV). Soluble LDLR can inhibit HCV infectivity;…”
Get full text

1376 LIVER TOXICITY OF THE MOST RECENTLY APPROVED ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS - OVERALL LOW RATE BUT INCREASED IN THE PRESENCE OF CHRONIC HEPATITIS C by Vispo, E, Fernandez-Montero, J.V, Labarga, P, Barreiro, P, Soriano, V

Get full text

985 INCREASING RATES OF ACUTE HEPATITIS C ALONG WITH HIGH RATES OF SYPHILIS IN HIV-POSITIVE MEN WHO HAVE SEX WITH MEN IN MADRID by Sanchez, C, Plaza, Z, Vispo, E, de Mendoza, C, Barreiro, P, Labarga, P, Poveda, E, Soriano, V

Get full text

496 CHANGES IN CIRCULATING HCV-RNA CONCENTRATIONS IN PATIENTS WITH CHRONIC HEPATITIS C IN THE ABSENCE OF ANTIVIRAL THERAPY by Barreiro, P, Labarga, P, Fernandez-Montero, J.V, Poveda, E, de Mendoza, C, Sanchez, C, Vispo, E, Soriano, V

Get full text

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients by Medrano, J., Resino, S., Vispo, E., Madejón, A., Labarga, P., Tuma, P., Martín-Carbonero, L., Barreiro, P., Rodriguez-Novoa, S., Jiménez-Nacher, I., Soriano, V.

“…The efficacy of current hepatitis C therapy in HIV/HCV‐coinfected patients is largely dependent on HCV genotype. The annual prevalence of HCV…”
Get full text

1220 TRIPLE COMBINATION THERAPY FOR HEPATITIS C WITH TELAPREVIR EXHIBITS GREATER EARLY ANTIVIRAL SUPPRESSION THAN WITH BOCEPREVIR REGARDLESS HIV STATUS by Benito, J.M, Bichoupan, K, Sanchez-Parra, C, Branch, A, Barreiro, P, Maida, I, Aguilera, A, Rallón, N.I, Labarga, P, Fernandez-Montero, J.V, Soriano, V, Dieterich, D

Get full text

882 GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTS by Neukam, K, Caruz, A, Rivero-Juárez, A, Labarga, P, Márquez, M, Real, L.M, Herrero, R, Rivero, A, Soriano, V, Pineda, J.A

Get full text

Level, phenotype and activation status of CD4⁺FoxP3⁺ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus by Rallón, N.I, López, M, Soriano, V, García-Samaniego, J, Romero, M, Labarga, P, García-Gasco, P, González-Lahoz, J, Benito, J.M

“…CD4⁺ regulatory T (Treg) cells have been involved in impaired immunity and persistence of viral infections. Herein, we report the level, phenotype and…”
Get full text

1230 IMPACT OF ANTIRETROVIRAL THERAPY ON THE VARIABILITY OF THE HCV NS5B POLYMERASE IN HIV/HCV COINFECTED PATIENTS by Plaza, Z, Soriano, V, Bar-Magen, T, Gonzalez, M.M, Di Lello, F, Marias, J, Labarga, P, Pineda, J.A, Poveda, E

Get full text